期刊
BIOLOGICAL & PHARMACEUTICAL BULLETIN
卷 39, 期 7, 页码 1159-1166出版社
PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/bpb.b16-00124
关键词
coenzyme Q(10); ulcerative colitis; iodoacetamide; oxidative stress; rat; sulfasalazine
Coenzyme Q(10) (Co-Q(10)) is a vitamin-like supplement which appears to be safe, with minimal side effects and low drug interaction potential. Co-Q(10) is used in the treatment of a variety of disorders related primarily to suboptimal cellular energy metabolism and oxidative injury. Studies supporting the efficacy of Co-Q(10) appear most promising for a variety of diseases, including ulcerative colitis (UC). The present investigation aims to elucidate the possible protective effects of Co-Q(10) against UC, as induced by the administration of iodoacetamide to adult male albino rats. In our study, Co-Q(10) showed potent anti-oxidant and anti-inflammatory activities through a significant increase in catalase activity and glutathione content. In addition, it significantly decreased myeloperoxidase activity, malondialdehyde content and nitrate/nitrite production. These results suggest that Co-Q(10) protects against UC in rats via anti-oxidant and anti-inflammatory potentials, and therefore seems promising for use in further clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据